Vernon, A C <br/><br/>
Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease.  [electronic resource] 

 -  The European journal of neuroscience  Oct 2005 
 - 1799-806 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0953-816X 
<br/><br/><label>Standard No.: </label>10.1111/j.1460-9568.2005.04362.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain Chemistry--drug effects<br/>Cell Death--drug effects<br/>Chromatography, High Pressure Liquid--methods<br/>Diagnostic Imaging<br/>Disease Models, Animal<br/>Drug Administration Schedule<br/>Excitatory Amino Acid Antagonists--administration & dosage<br/>Functional Laterality--physiology<br/>Immunohistochemistry--methods<br/>Ligands<br/>Male<br/>Neuroprotective Agents--administration & dosage<br/>Oxidopamine--toxicity<br/>Parkinson Disease--etiology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Metabotropic Glutamate--physiology<br/>Substantia Nigra--drug effects<br/>Sympatholytics--toxicity<br/>Tyrosine 3-Monooxygenase--metabolism